TwoStep Therapeutics
PrivateLast Round
Series A
Jan 20, 2026
Est. Valuation
$64.5M
Total Funding Raised
$29.8M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
TwoStep Therapeutics is a biotechnology company developing a pipeline of targeted cancer therapies for solid tumors using a unique polyspecific integrin-binding peptide (PIP) that selectively binds to multiple targets highly expressed on solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TwoStep Therapeutics Comparables
Compare TwoStep Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Actithera | 88% | |
| ARTBIO | 86% | |
| Abdera Therapeutics | 86% | |
TwoStep Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 20, 2026 | ||||
| Seed | Mar 19, 2025 | ||||
| Seed | Jun 25, 2024 |
Key People
Founding team and executive leadership
TwoStep Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | Series A, Seed |
| Alexandria Venture Investments | Seed |
| 2048 Ventures | Seed, Series A |
| Cooley | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
Grew 38% QoQ from 8 to 11 employees.
TwoStep Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TwoStep Therapeutics's valuation, stock price, and market status.